A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Solid Tumor · High Grade Serous Adenocarcinoma of Ovary · Squamous Non-small-cell Lung Cancer · Triple Negative Breast Cancer · Head and Neck Squamous Cell Carcinoma · Ovarian Carcinosarcoma · Uterine Carcinosarcoma · Uterine Serous Carcinoma · Endometrium Cancer · Chromosomal Instability

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Southern California, Los Angeles, California, United States
Contact: Study coordinator (Xiomara Menendez, RN) · Xiomara.Menendez@med.usc.edu
Contact: Study coordinator (Lorraine Martinez, MD) · Lorraine.Martinez@med.usc.edu
Hoag Memorial Hospital, Newport Beach, California, United States
Contact: Study coordinator (Patrice Jones) · patrice.jones@hoag.org · 9497645501
University of Colorado Cancer Center, Aurora, Colorado, United States
Contact: Study coordinator (Yasmin Yazdani Farsad) · YASMIN.YAZDANIFARSAD@CUANSCHUTZ.EDU · 303-724-9403
Yale Cancer Center, New Haven, Connecticut, United States
Contact: Study coordinator (Ingrid Palma) · ingrid.palma@yale.edu · 203-833-1034
Kellogg Cancer Center, Evanston, Illinois, United States
Contact: Study coordinator (Michele Britto) · mbritto@northshore.org · (847) 570-2109
Community Health Network, Indianapolis, Indiana, United States
Contact: Study coordinator (Megan Haas) · mhaas2@ecommunity.com
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Contact: Study coordinator (Matthew Bark) · Mbark1@jhmi.edu · 443-927-8743
University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Cancer AnswerLine) · CancerAnswerLine@med.umich.edu · 800-865-1125
START Midwest, Grand Rapids, Michigan, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Claire Friedman, MD) · friedmac@mskcc.org · 646-888-4593
The Christ Hospital, Cincinnati, Ohio, United States
Contact: Study coordinator (Abby Reed, RN) · abby.reed@thechristhospital.com · 513-585-1140
Women & Infants Hospital, Providence, Rhode Island, United States
Contact: Study coordinator (Emma Locke) · oncologyresearch@wihri.org · 401-430-8181
M.D. Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Ecaterina Dumbrava, MD) · eeileana@mdanderson.org · 713-792-3934
Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Clinical Trials Office) · cccto@mcw.edu · 414-805-8900

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States

KN035 for dMMR/MSI-H Advanced Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE2

Beijing, China

A Study of YL242 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

New Haven, United States · Sarasota, United States

A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation

Advanced Solid Tumors Cancer · PDAC · CRC (Colorectal Cancer)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China · Guangzhou, China